|
|
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial
Piotr Ponikowski
,
Bridget-Anne Kirwan
,
Stefan Anker
,
Theresa Mcdonagh
,
Maria Dorobantu
,
et al.
Journal articles
inserm-03935081v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Abnormalities of Potassium in Heart Failure JACC State-of-the-Art Review
João Pedro Ferreira
,
Javed Butler
,
Patrick Rossignol
,
Bertram Pitt
,
Stefan D. Anker
,
et al.
Journal articles
hal-03490821v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
Paul W Armstrong
,
Burkert Pieske
,
Kevin J Anstrom
,
Justin Ezekowitz
,
Adrian F Hernandez
,
et al.
Journal articles
inserm-03935267v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trial
Wolfram Doehner
,
Stefan D Anker
,
Javed Butler
,
Faiez Zannad
,
Gerasimos Filippatos
,
et al.
Journal articles
hal-03792414v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload
Milton Packer
,
Stefan D Anker
,
Javed Butler
,
Gerasimos Filippatos
,
João Pedro Ferreira
,
et al.
Journal articles
hal-03185917v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Rationale and design of the Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure Trial (ARISE-HF) in patients with high-risk diabetic cardiomyopathy
James L Januzzi
,
Javed Butler
,
Stefano del Prato
,
Justin A Ezekowitz
,
Nasrien E Ibrahim
,
et al.
Journal articles
hal-03884375v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Influence of endpoint definitions on the effect of empagliflozin on major renal outcomes in the EMPEROR‐Preserved trial
Milton Packer
,
Faiez Zannad
,
Javed Butler
,
Gerasimos Filippatos
,
Joao Pedro Ferreira
,
et al.
Journal articles
hal-03357918v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure
João Pedro Ferreira
,
Faiez Zannad
,
Stuart J Pocock
,
Stefan D Anker
,
Javed Butler
,
et al.
Journal articles
hal-03185873v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study
Ewa A Jankowska
,
Bridget-Anne Kirwan
,
Mikhail Kosiborod
,
Javed Butler
,
Stefan D Anker
,
et al.
Journal articles
inserm-03934856v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Hemoglobin and Clinical Outcomes in the Vericiguat Global Study in Patients With Heart Failure and Reduced Ejection Fraction (VICTORIA)
Justin A Ezekowitz
,
Yinggan Zheng
,
Alain Cohen-Solal
,
Vojtěch Melenovský
,
Jorge Escobedo
,
et al.
Journal articles
inserm-03934690v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Effect of Empagliflozin on Worsening Heart Failure Events in Patients with Heart Failure and a Preserved Ejection Fraction: The EMPEROR-Preserved Trial
Milton Packer
,
Javed Butler
,
Faiez Zannad
,
Gerasimos Filippatos
,
Joao Pedro Ferreira
,
et al.
Journal articles
hal-03358043v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial
Stefan D Anker
,
Javed Butler
,
Gerasimos Filippatos
,
Muhammad Shahzeb Khan
,
Nikolaus Marx
,
et al.
Journal articles
hal-03014260v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Empagliflozin, Health Status, and Quality of Life in Patients with Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial
Javed Butler
,
Gerasimos Filippatos
,
Tariq Jamal Siddiqi
,
Martina Brueckmann
,
Michael Böhm
,
et al.
Journal articles
hal-03467783v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes
Gerasimos Filippatos
,
Javed Butler
,
Dimitrios Farmakis
,
Faiez Zannad
,
Anne Pernille Ofstad
,
et al.
Journal articles
hal-03791576v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
How can we optimise health technology assessment and reimbursement decisions to accelerate access to new cardiovascular medicines?
Martin R Cowie
,
Biykem Bozkurt
,
Javed Butler
,
Andrew Briggs
,
Maria Kubin
,
et al.
Journal articles
hal-03800780v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Effect of Empagliflozin on Circulating Proteomics in Heart Failure: Mechanistic Insights from the EMPEROR Program
Faiez Zannad
,
João Pedro Ferreira
,
Javed Butler
,
Gerasimos Filippatos
,
James L Januzzi
,
et al.
Journal articles
hal-03793111v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR‐Preserved trial
Stefan D Anker
,
Javed Butler
,
Gerasimos Filippatos
,
Muhammad Shahzeb Khan
,
João Pedro Ferreira
,
et al.
Journal articles
hal-03758946v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial
Javed Butler
,
Stefan D Anker
,
Gerasimos Filippatos
,
Muhammad Shahzeb Khan
,
João Pedro Ferreira
,
et al.
Journal articles
hal-03115141v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure
João Pedro Ferreira
,
Faiez Zannad
,
Javed Butler
,
Gerasimos Filippatos
,
Stuart J Pocock
,
et al.
Journal articles
hal-03798543v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Concentration‐dependent clinical and prognostic importance of high‐sensitivity cardiac troponin T in heart failure and a reduced ejection fraction and the influence of empagliflozin: the EMPEROR ‐Reduced trial
Milton Packer
,
James L Januzzi
,
Joao Pedro Ferreira
,
Stefan D Anker
,
Javed Butler
,
et al.
Journal articles
hal-03717440v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Early changes in estimated glomerular filtration rate post‐initiation of empagliflozin in EMPEROR‐Reduced
Faiez Zannad
,
João Pedro Ferreira
,
John Gregson
,
Bettina Johanna Kraus
,
Michaela Mattheus
,
et al.
Journal articles
hal-03813870v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction
Javed Butler
,
Gerasimos Filippatos
,
Jamal Siddiqi
,
João Pedro Ferreira
,
Martina Brueckmann
,
et al.
Journal articles
hal-03795027v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Sacubitril/valsartan for the management of heart failure: A perspective viewpoint on current evidence
Massimo Volpe
,
Johann Bauersachs
,
Antoni Bayés-Genís
,
Javed Butler
,
Alain Cohen-Solal
,
et al.
Journal articles
inserm-03935024v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Dosing of losartan in men versus women with heart failure with reduced ejection fraction: the HEAAL trial
João Pedro Ferreira
,
Marvin A Konstam
,
John J.V. Mcmurray
,
Javed Butler
,
Nicolas Girerd
,
et al.
Journal articles
hal-03701735v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Empagliflozin Improves Cardiovascular and Renal Outcomes in Heart Failure Irrespective of Systolic Blood Pressure
Michael Böhm
,
Stefan D Anker
,
Javed Butler
,
Gerasimos Filippatos
,
João Pedro Ferreira
,
et al.
Journal articles
hal-03380278v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Aspirin use is associated with increased risk for incident heart failure: a patient‐level pooled analysis
Blerim Mujaj
,
Zhen‐yu Zhang
,
Wen‐Yi Yang
,
Lutgarde Thijs
,
Fang‐fei Wei
,
et al.
Journal articles
hal-03467860v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction
Javed Butler
,
Milton Packer
,
Gerasimos Filippatos
,
Joao Pedro Ferreira
,
Cordula Zeller
,
et al.
Journal articles
hal-03478833v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Baseline features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial
Burkert Pieske
,
Mahesh J Patel
,
Cynthia M Westerhout
,
Kevin J Anstrom
,
Javed Butler
,
et al.
Journal articles
inserm-03935803v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Outcomes with empagliflozin in heart failure with preserved ejection fraction using DELIVER‐like endpoint definitions
Stefan D Anker
,
Tariq Jamal Siddiqi
,
Gerasimos Filippatos
,
Faiez Zannad
,
João Pedro Ferreira
,
et al.
Journal articles
hal-03797421v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Empagliflozin Improves Outcomes in Patients With Heart Failure and Preserved Ejection Fraction Irrespective of Age
Michael Böhm
,
Javed Butler
,
Gerasimos Filippatos
,
João Pedro Ferreira
,
Stuart J Pocock
,
et al.
Journal articles
hal-03791473v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|